Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Relay Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get RLAY alerts

About Peter Amar

Peter Amar has spoken on 1 investor event across 1 company, most recently for Relay Therapeutics, Inc. on November 10, 2026. Relay Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Relay Therapeutics, Inc. includes Thomas Catinazzo (CFO), Brian R. Adams (General Counsel), Claire Mazumdar (Board Member) and 4 others.

Peter Amar on recent calls

“That's exactly been the experience, that the PIK3CA mutant patients do benefit from CDK4-6 inhibitors, but not to the same extent as PIK3CA wild-type patients.”
Other, Guggenheim 3rd Annual Healthcare Innovation Conference ·

Affiliation history

Company network

Leadership on record at Relay Therapeutics, Inc.

Recent activity